Chemicals And Allied Products - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Chemicals industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Chemicals And Allied Products - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Chemicals And Allied Products
Corporate Insider Buy Sell Ratio (Insider Count) - Chemicals And Allied Products
Chemicals And Allied Products - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-16 ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 4 OYLER JOHN S - Sale D 325.062 -6,883
2025-09-16 OLMA / Olema Pharmaceuticals, Inc. 4 Harmon Cyrus S - Sale D 8.04 -10,000
2025-09-16 ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 4 OYLER JOHN S - Sale D 326.9029 -4,008
2025-09-16 ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 4 OYLER JOHN S - Sale D 326.1362 -12,446
2025-09-16 MNKD / MannKind Corporation 4 Tross Stuart A S - Sale D 5.34 -47,000
2025-09-16 SRRK / Scholar Rock Holding Corporation 4 Peng Katie S - Sale D 32.4761 -930
2025-09-16 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 1.5401 -447,278
2025-09-16 ALXO / ALX Oncology Holdings Inc. 4 Lettmann Jason P - Purchase D 1.066 21,070
2025-09-16 LFVN / LifeVantage Corporation 4 Lewis Darwin P - Purchase D 10.8499 450
2025-09-16 IMMX / Immix Biopharma, Inc. 4 Morris Gabriel S P - Purchase D 1.97 2,600
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. M - Exercise D 4.85 15,000
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. M - Exercise D 4.95 25,000
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 TABUTEAU HERRIOT M - Exercise D 8.02 19,719
2025-09-16 KYMR / Kymera Therapeutics, Inc. 4 Mainolfi Nello M - Exercise D 2.08 30,000
2025-09-16 CRMD / CorMedix Inc. 4 Duncan Gregory Scott M - Exercise D 8.32 13,333
2025-09-16 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-16 PTGX / Protagonist Therapeutics, Inc. 4 PATEL DINESH V PH D G - Gift D -620
2025-09-16 TARS / Tarsus Pharmaceuticals, Inc. 4 LINK WILLIAM J PHD G - Gift D -2,000
2025-09-16 CLX / The Clorox Company 4 Reynolds Eric H A - Award D 124.8500 9,611
2025-09-16 CLX / The Clorox Company 4 Marriner Kirsten A - Award D 124.8500 7,689
2025-09-16 CLX / The Clorox Company 4 Rendle Linda J A - Award D 124.8500 34,281
2025-09-16 CLX / The Clorox Company 4 Bellet Luc A - Award D 124.8500 7,368
2025-09-16 CLX / The Clorox Company 4 Hilt Angela C A - Award D 124.8500 7,048
2025-09-16 CLX / The Clorox Company 4 Barton Nina A - Award D 124.8500 7,208
2025-09-16 CLX / The Clorox Company 4 Peck Laurene E A - Award D 124.8500 1,441
2025-09-16 CLX / The Clorox Company 4 Hyder Chris T A - Award D 124.8500 7,208
2025-09-16 CLX / The Clorox Company 4 Grier Stacey A - Award D 124.8500 3,364
2025-09-15 KPTI / Karyopharm Therapeutics Inc. 4 Cheng Sohanya Roshan S - Sale D 6.43 -325
2025-09-15 CSW / CSW Industrials, Inc. 4 Armes Joseph B S - Sale D 250 -1,000
2025-09-15 RNA / Avidity Biosciences, Inc. 4 McCarthy Teresa S - Sale D 41.4095 -15,000
2025-09-15 DD / DuPont de Nemours, Inc. 4 Larrabee Steven P. S - Sale D 76.98 -4,000
2025-09-15 GILD / Gilead Sciences, Inc. 4 Mercier Johanna S - Sale D 113.57 -3,000
2025-09-15 KPTI / Karyopharm Therapeutics Inc. 4 Paulson Richard A. S - Sale D 6.43 -1,257
2025-09-15 KPTI / Karyopharm Therapeutics Inc. 4 Rangwala Reshma S - Sale D 6.43 -408
2025-09-15 DD / DuPont de Nemours, Inc. 4 Larrabee Steven P. S - Sale D 77.19 -39,208
2025-09-15 NUVL / Nuvalent, Inc. 4 Porter James Richard S - Sale D 79.30 -16,080
2025-09-15 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 398.1889 -1,460
2025-09-15 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 397.7086 -2,540
2025-09-15 NUVL / Nuvalent, Inc. 4 Porter James Richard S - Sale D 80.12 -2,097
2025-09-15 NUVL / Nuvalent, Inc. 4 Porter James Richard S - Sale D 78.42 -8,823
2025-09-15 KPTI / Karyopharm Therapeutics Inc. 4 Poulton Stuart S - Sale D 6.43 -401
2025-09-15 KPTI / Karyopharm Therapeutics Inc. 4 Abate Kristin S - Sale D 6.43 -23
2025-09-15 CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 4 HUSSAIN IQBAL J S - Sale D 21.8501 -6,000
2025-09-15 MLYS / Mineralys Therapeutics, Inc. 4 Rodman David Malcom S - Sale D 36.4748 -2,065
2025-09-15 ADMA / ADMA Biologics, Inc. 4 Grossman Adam S S - Sale D 16.13 -6,000
2025-09-15 KNSA / Kiniksa Pharmaceuticals, Ltd. 4 Tessari Eben S - Sale D 37 -356
2025-09-15 CYTK / Cytokinetics, Incorporated 4 Blum Robert I S - Sale D 49.77 -5,000
2025-09-15 KNSA / Kiniksa Pharmaceuticals, Ltd. 4 Tessari Eben S - Sale D 36.45 -16,044
2025-09-15 RVMD / Revolution Medicines, Inc. 4 Kelsey Stephen Michael S - Sale D 45.9175 -23,682
2025-09-15 GILD / Gilead Sciences, Inc. 4 Dickinson Andrew D S - Sale D 113.57 -2,500
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)